Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
clinical trials
deals
life sciences
national blog main
abbvie
alexion pharmaceuticals
allergan
alnylam pharmaceuticals
alzheimer's disease
boehringer ingelheim
crispr
cynthia collins
dicerna pharamceuticals
editas medicine
fda
gene editing
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
leber congenital amaurosis type 10
michelle robertson
national top stories
parkinson's disease
patisiran
rare diseases
rna interference
roche
san francisco blog main
voyager therapeutics
world health organization
What
gene
2
×
medicines
research
2
×
abbvie
alliance
biotech
caught
causing
dicerna
disease
drug
editas
editing
exits
experimental
eye
genetic
hepatitis
intended
pact
partnership
pay
pharma
pharmaceuticals
producing
protein
pruning
returning
rights
roche
stop
team
terminated
treatment
Language
unset
Current search:
gene
×
boston
×
research
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
